Very exciting news!!
Seven New Stocks Added to the Canadian Marijuana Index
Cannabix Technologies Inc.
Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) is a Vancouver, B.C. based technology company. Cannabix is developing tools for law enforcement and the workplace to detect THC in the breath. The primary product is a marijuana breathalyzer designed for law enforcement and the workplace. The portable device would be used to provide detection of THC at the roadside to identify drivers under the influence of marijuana.
Harvest One Cannabis
Harvest One Cannabis Inc. (TSX: HVST) OTC: HRVOF) is a global cannabis company focused on servicing both the medical and recreational cannabis markets. Harvest One is serving as the parent company of a wholly-owned medical subsidiary Satipharm AG and a wholly owned horticultural subsidiary United Greeneries.
Satipharm AG is based in Switzerland. Satipharm specializes in the development and production of dietary supplements with a focus on legally accessible cannabidiol (CBD). The primary product is CBD Gelpell Microgel Capsules. The capsules are made from organic CDB made according to GMP pharmaceutical standards. Each capsule contains little 2mm round gel caps that deliver a measured dose of CBD.
United Greeneries is a Vancouver based grower of cannabis. Current production is only about 1,000 kilos. Expansion plans call for production to hit 75,000 kilos in 2019. Retail sales of two branded lines, Captain’s Choice and Royal High, is set to begin in February 2018.
InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. (CSE: IN) (OTC: IMLFF) is a drug discovery, and development company uniquely focused on the therapeutic potential of cannabinoids. InMed is currently developing two products in its drug pipeline: INM-750, for the treatment of Epidermolysis Bullosa, and INM-085, for the treatment of Glaucoma. Both are topical products using multiple cannabinoids. IMM-750 is applied to the skin and IMM-085 is applied directly to the eye.
Invictus MD Strategies Corp.
Invictus MD Strategies Corp. (TSXV: IMH) (OTC: IVITF) is in the business of growing marijuana. Capacity for 2018 is 26,000 kilos. Plans are in place to increase capacity to 76,000 kilos in 2019.
Invictus uses a combination of wholly-owned facilities and jointly owned facilities to operate its business. It claims to have 250 acres of land available for cultivation. Development is contingent on increased demand.
MYM Nutraceuticals Inc.
MYM Nutraceuticals Inc. (CSE: MYM) (OTC: MYMMF) grows cannabis and manufactures cannabis products. MYM is rolling out the development of cultivation spaces with the goal of reaching more than 1.5 million square feet in 2020. The company is a 35% partner in a 1.2 million square foot facility under construction in Australia.
THC Biomed Intl. Ltd.
THC Biomed Intl. Ltd. (CSE: THC) (OTC: THCBF) was founded in 2012. THC Biomed is headquartered in Kelowna, British Columbia, Canada. THC is a Canadian federally Licensed Producer of Medical Marijuana focusing on plant innovation and life sciences, with the emphasis on medical cannabis.
In a universe of corporate websites written to confuse rather than illuminate, THC Biomed is refreshing. The site’s primary purpose is to generate revenue while providing all the other information you may want. Directly below the header picture the site tells you that marijuana is available for $6 per gram and clones for $20.
WeedMD, Inc.
WeedMD, Inc. (TSXV: WMD) is a licensed producer and seller of medical marijuana whose primary focus is providing consistent, quality medicine to the assisted living and long-term care markets in Canada through a comprehensive platform developed exclusively for that industry.
WeedMD is not neglecting other business opportunities. WeedMD provides service to all patients and is preparing for the potential nationwide legalization of recreational marijuana.
